140 related articles for article (PubMed ID: 3621113)
1. The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer.
Kamby C; Guldhammer B; Vejborg I; Rossing N; Dirksen H; Daugaard S; Mouridsen HT
Cancer; 1987 Sep; 60(6):1306-12. PubMed ID: 3621113
[TBL] [Abstract][Full Text] [Related]
2. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiologic characteristics of bone metastases in breast cancer.
Kamby C; Vejborg I; Daugaard S; Guldhammer B; Dirksen H; Rossing N; Mouridsen HT
Cancer; 1987 Nov; 60(10):2524-31. PubMed ID: 3664434
[TBL] [Abstract][Full Text] [Related]
4. Prognostic indicators of metastatic bone disease in human breast cancer.
Kamby C; Rasmussen BB; Kristensen B
Cancer; 1991 Nov; 68(9):2045-50. PubMed ID: 1913553
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer.
Mathieu MC; Friedman S; Bosq J; Caillou B; Spielmann M; Travagli JP; Contesso G
Breast Cancer Res Treat; 1990 Jan; 15(1):21-6. PubMed ID: 2328327
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
Diel IJ; Kaufmann M; Goerner R; Costa SD; Kaul S; Bastert G
J Clin Oncol; 1992 Oct; 10(10):1534-9. PubMed ID: 1403032
[TBL] [Abstract][Full Text] [Related]
7. The value of bone marrow biopsy in breast cancer at the time of first relapse. A prospective study.
Ceci G; Franciosi V; Passalacqua R; Di Blasio B; Boni C; Lottici R; De Lisi V; Nizzoli R; Guazzi A; Cocconi G
Cancer; 1988 Mar; 61(5):1041-5. PubMed ID: 3338048
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow biopsy in patients with malignant neoplasms other than lymphomas or leukemia.
Cohen Y; Gershoni-Baruch R; Lichtic C
Acta Haematol; 1979; 62(4):181-4. PubMed ID: 119409
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of bone marrow metastases: evaluation of 58 cases.
Kucukzeybek BB; Calli AO; Kucukzeybek Y; Bener S; Dere Y; Dirican A; Payzin KB; Ozdemirkiran F; Tarhan MO
Indian J Pathol Microbiol; 2014; 57(3):396-9. PubMed ID: 25118730
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow biopsy in solid cancer.
Cohen Y; Zidan J; McShan D
Acta Haematol; 1982; 68(1):14-9. PubMed ID: 6812351
[TBL] [Abstract][Full Text] [Related]
12. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
13. Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest.
Ridell B; Landys K
Cancer; 1979 Nov; 44(5):1782-8. PubMed ID: 498049
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow metastases without cortical bone involvement in breast cancer patients.
DiStefano A; Tashima CK; Yap HY; Hortobagyi GN
Cancer; 1979 Jul; 44(1):196-8. PubMed ID: 455244
[TBL] [Abstract][Full Text] [Related]
15. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging.
Sanal SM; Flickinger FW; Caudell MJ; Sherry RM
J Clin Oncol; 1994 Jul; 12(7):1415-21. PubMed ID: 8021732
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in the bone marrow of patients with breast cancer.
Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic bone disease. Strategies for imaging].
Scutellari PN; Antinolfi G; Galeotti R; Giganti M
Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
19. The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulness.
Ingle JN; Tormey DC; Tan HK
Cancer; 1978 Feb; 41(2):670-4. PubMed ID: 630544
[TBL] [Abstract][Full Text] [Related]
20. How far investigations for occult metastases in breast cancer aid the clinician.
Glynne-Jones R; Young T; Ahmed A; Ell PJ; Berry RJ
Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):65-72. PubMed ID: 2031885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
